Caner Saygin

17PUBLICATIONS
231CO-AUTHORS
Haematological tumoursMolecular evolutionCancer geneticsGene and molecular therapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Apr 08, 2026
Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis.

Morgan Drucker, Darren Lee, Michael S Bowman

|Mar 30, 2026
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL.

Caner Saygin, Matthew T Witkowski, Sinan Cetin

|Mar 04, 2026
Targeting Menin in T-lineage Acute Lymphoblastic Leukemia.

Kathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold

|Aug 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.

Nicole S Arellano, William L Heaton, Mirielle C Nauman

Pageof 3

Frequent Collaborators

7 joint publications

Anand Patel

6 joint publications

Wendy Stock

3 joint publications

Talha Badar

3 joint publications

Olatoyosi Odenike